Such phenomenon provided support to our anticipation to develop a cardiac patch, which can prevent remodeling and chronic heart failure after MI by releasing rhACE2 in-situ continuously and providing a counter AngII niche. The gene discussed is AGT; the disease is myocardial infarction.